Vitamin D levels in children with COVID-19: a report from Turkey
dc.contributor.author | Alpcan, Aysegul | |
dc.contributor.author | Tursun, Serkan | |
dc.contributor.author | Kandur, Yasar | |
dc.date.accessioned | 2025-01-21T16:55:53Z | |
dc.date.available | 2025-01-21T16:55:53Z | |
dc.date.issued | 2021 | |
dc.department | Kırıkkale Üniversitesi | |
dc.description.abstract | Several studies have demonstrated that higher levels of vitamin D are associated with better prognosis and outcomes in infectious diseases. We aimed to compare the vitamin D levels of paediatric patients with mild/moderate coronavirus disease 2019 (COVID-19) disease and a healthy control group. We retrospectively reviewed the medical records of patients who were hospitalised at our university hospital with the diagnosis of COVID-19 during the period between 25 May 2020 and 24 December 2020. The mean age of the COVID-19 patients was 10.7 +/- 5.5 years (range 1-18 years); 43 (57.3%) COVID-19 patients were male. The mean serum vitamin D level was significantly lower in the COVID-19 group than the control group (21.5 +/- 10.0 vs. 28.0 +/- 11.0 IU, P < 0.001). The proportion of patients with vitamin D deficiency was significantly higher in the COVID-19 group than the control group (44% vs. 17.5%, P < 0.001). Patients with low vitamin D levels were older than the patients with normal vitamin D levels (11.6 +/- 4.9 vs. 6.2 +/- 1.8 years, P = 0.016). There was a significant male preponderance in the normal vitamin D group compared with the low vitamin D group (91.7% vs. 50.8%, P = 0.03). C-reactive protein level was higher in the low vitamin D group, although the difference did not reach statistical significance (9.6 +/- 2.2 vs. 4.5 +/- 1.6 mg/l, P = 0.074). Our study provides an insight into the relationship between vitamin D deficiency and COVID-19 for future studies. Empiric intervention with vitamin D can be justified by low serum vitamin D levels. | |
dc.identifier.doi | 10.1017/S0950268821001825 | |
dc.identifier.issn | 0950-2688 | |
dc.identifier.issn | 1469-4409 | |
dc.identifier.pmid | 34375576 | |
dc.identifier.scopus | 2-s2.0-85113835254 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.uri | https://doi.org/10.1017/S0950268821001825 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/25866 | |
dc.identifier.volume | 149 | |
dc.identifier.wos | WOS:000683532200001 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Cambridge Univ Press | |
dc.relation.ispartof | Epidemiology and Infection | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_20241229 | |
dc.subject | Children; COVID-19; vitamin D | |
dc.title | Vitamin D levels in children with COVID-19: a report from Turkey | |
dc.type | Article |